Carregant...
Interfering with leukemic stem cells
Kinase inhibitors such as imatinib (Gleevec) have improved the outlook for many patients with chronic myeloid leukemia and related blood disorders. But such drugs fail to target the leukemia stem cell population and may not be curative. Krause and Van Etten discuss several clinical studies that sugg...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490184/ https://ncbi.nlm.nih.gov/pubmed/18463658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm0508-494 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|